Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
1,405
-10
-0.71%
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Kalbe Farma Tbk PT (KLBF)
Add to/Remove from a Portfolio
Add to Watchlist
- Volume: 2,857,500
- Bid/Ask: 1,400 / 1,405
- Day's Range: 1,400 - 1,420
Kalbe Farma
1,405
-10
-0.71%
- Discussions
- Recent Sentiments
- User Rankings
KLBF User Rankings
Bellow, users are ranked according to the performance of their sentiments for the Kalbe Farma Tbk PT stock.
| Rank | Username | Total | Closed | Winning | Win % | Chg. % |
|---|---|---|---|---|---|---|
| 1 | Rizqi Akbar | 1 | 1 | 1 | 100 | +17.36% |
| 2 | Agung Kristianto | 1 | 1 | 1 | 100 | +14.98% |
| 3 | Syuryadi Amirudin | 1 | 1 | 1 | 100 | +14.93% |
| 4 | dede sulaiman | 1 | 1 | 1 | 100 | +14.73% |
| 5 | Rendy Satrya | 1 | 1 | 1 | 100 | +14.73% |
| 6 | Yus Rizal | 2 | 2 | 1 | 50 | +14.05% |
| 7 | Abdul Hakim | 1 | 1 | 1 | 100 | +12.7% |
| 8 | Hayadi Nur | 1 | 1 | 1 | 100 | +11.26% |
| 9 | Ade Ahmad Fauzie | 1 | 1 | 1 | 100 | +10.2% |
| 10 | Kevin Haris Mauludi II | 1 | 1 | 1 | 100 | +10.2% |
| 11 | aditya riadi | 1 | 1 | 1 | 100 | +9.09% |
| 12 | TONO TONS | 1 | 1 | 1 | 100 | +7.75% |
| 13 | Yosheko Casimira | 1 | 1 | 1 | 100 | +7.35% |
| 14 | febby sukmawijaya | 1 | 1 | 1 | 100 | +7.35% |
| 15 | Sofyan Helmi | 1 | 1 | 1 | 100 | +7.01% |
| 16 | agnes kusuma | 1 | 1 | 1 | 100 | +7.01% |
| 17 | Elga Muhammad | 1 | 1 | 1 | 100 | +6.03% |
| 18 | Dio Ruliansyah | 1 | 1 | 1 | 100 | +5.84% |
| 19 | Surya Pandean | 1 | 1 | 1 | 100 | +5.48% |
| 20 | Candra Sakti | 1 | 1 | 1 | 100 | +5.45% |
| 21 | Tumpal Sinaga | 1 | 1 | 1 | 100 | +4.76% |
| 22 | Christian Renaldy | 1 | 1 | 1 | 100 | +4.72% |
| 23 | Areksajaya Putu | 1 | 1 | 1 | 100 | +4.68% |
| 24 | Munawwarah Irhamsyah | 1 | 1 | 1 | 100 | +4.64% |
| 25 | Hady Marzuki | 1 | 1 | 1 | 100 | +4.56% |
| 26 | Kon Yosua | 1 | 1 | 1 | 100 | +4.41% |
| 27 | Amar sigli | 2 | 2 | 1 | 50 | +3.76% |
| 28 | Nur Arif Hendra | 1 | 1 | 1 | 100 | +3.7% |
| 29 | Adhyanovic Hadi Pradipta | 1 | 1 | 1 | 100 | +3.46% |
| 30 | Thomas Suparjono | 1 | 1 | 1 | 100 | +3.25% |
| 31 | Dean Reyhan | 1 | 1 | 1 | 100 | +3.14% |
| 32 | Thedy Wijaya | 1 | 1 | 1 | 100 | +3.11% |
| 33 | prabu ningrat | 1 | 1 | 1 | 100 | +3.07% |
| 34 | Semanggi Anime | 1 | 1 | 1 | 100 | +2.72% |
| 35 | 봉숙 노 | 1 | 1 | 1 | 100 | +2.72% |
| 36 | anjar wiyono | 1 | 1 | 1 | 100 | +2.46% |
| 37 | aprian yordan | 1 | 1 | 1 | 100 | +2.05% |
| 38 | Ivan Chiang | 2 | 2 | 1 | 50 | +1.99% |
| 39 | satrio utomo | 1 | 1 | 1 | 100 | +1.91% |
| 40 | Hendrik Kusbiyanto | 1 | 1 | 1 | 100 | +1.55% |
| 41 | Firman Syah | 1 | 1 | 1 | 100 | +1.36% |
| 42 | Yosua Manurung | 1 | 1 | 1 | 100 | +1.21% |
| 43 | Kardika Mustafa | 1 | 1 | 1 | 100 | +1.2% |
| 44 | rina Nugroho | 1 | 1 | 1 | 100 | +0.98% |
| 45 | Roky Kartiko | 1 | 1 | 1 | 100 | +0.94% |
| 46 | Lasaze Craft | 1 | 1 | 1 | 100 | +0.66% |
| 47 | Jack Bro | 1 | 1 | 1 | 100 | +0.32% |
| 48 | Pandu Aditya | 1 | 1 | 1 | 100 | +0.3% |
| 49 | Azis Luthfi | 1 | 1 | 0 | 0 | 0% |
| 50 | Anwar Ramadhan | 1 | 1 | 0 | 0 | 0% |
Write your thoughts about Kalbe Farma Tbk PT
Are you sure you want to delete this chart?
Delete Cancel
Replace the attached chart with a new chart ?
Replace Cancel
Comment Guidelines
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review